The Klingenstein Third Generation Foundation was established in 1993 through a capital grant from the Esther A. and Joseph Klingenstein Fund. The six trustees of the Klingenstein Third Generation Foundation are the grandchildren of Esther A. & Joseph Klingenstein. Joseph Klingenstein was a founding partner of Wertheim & Company.

The Klingenstein Third Generation Foundation seeks to:

  • Encourage a meaningful, long-term contribution to the field of child and adolescent ADHD and depression by supporting relevant, cutting-edge scientific research;
  • Enlarge the academic and research pool by nurturing the talents of high-quality medical students and graduates from medical schools and graduate programs;
  • Encourage major medical institutions to support young investigators in the critical early stages of their careers to secure financial support (such as K awards and other entry level grants) from the National Institutes of Mental Health (NIMH).

The Foundation pursues these goals through three fellowships (funding post-doctoral research in ADHD, depression, and access to care), and a medical student program. The Foundation does not accept proposals for grants outside these areas unless in response to a KTGF issued RFP.